[1]CHEN D, QIAN JM.Chronic active Epstein-Barr virus infection[J].Chin J Gastroenterol Hepatol, 2016, 25 (10) :1193-1197. (in Chinese) 陈丹, 钱家鸣.慢性活动性EB病毒感染[J].胃肠病学和肝病学杂志, 2016, 25 (10) :1193-1197.
|
[2]OKANO M, KAWA K, KIMURA H, et al.Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection[J].Am JHematol, 2005, 80 (1) :64-69.
|
[3]COHEN JI.Optimal treatment for chronic active Epstein-Barr virus disease[J].Pediatr Transplant, 2009, 13 (4) :393-396.
|
[4]SAWADA A, INOUE M, KAWA K.How we treat chronic active Epstein-Barr virus infection[J].Int J Hematol, 2017, 105 (4) :406-418.
|
[5]SAWADA A, INOUE M, KOYAMA-SATO M, et al.Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases[J].Biol Blood Marrow Transplant, 2014, 20 (2) :214-221.
|
[6]CHIU CF, CHOW KC, LIN TY, et al.Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan.Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19[J].Am J Clin Pathol, 2000, 113 (6) :774-781.
|
[7]RAMARAJ K, RAVIKUMAR T, REDDY V.Epstein-Barr virus associated hemophagocytic lymphohistiocytosis presenting with lymphadenopathy diagnosed as Kikuchi-Fujimoto disease:a case report from South India[J].Int J Contemp Pediatr, 2016, 3 (1) :264-267.
|
[8]QI LN, WANG SH, GUO XL, et al.A case of subacute severe hepatitis caused by HEV and EBV coinfection[J].J Clin Hepatol, 2017, 33 (4) :728-729. (in Chinese) 奇丽娜, 王淑华, 郭芗羚, 等.HEV重叠EB病毒感染致亚急性重型肝炎1例报告[J].临床肝胆病杂志, 2017, 33 (4) :728-729.
|
[9]WANG HS, WEI Q, LEI MM, et al.Acute hepatitis B complicated by EBV virus infection:a case repot[J].J Clin Hepatol, 2017, 33 (4) :725-727. (in Chinese) 王洪莎, 魏祺, 雷嫚嫚, 等.急性乙型肝炎合并EB病毒感染1例报告[J].临床肝胆病杂志, 2017, 33 (4) :725-727.
|
[10]YEN A, FEARNEYHOUGH P, RAIMER SS, et al.EBV-associated Kikuchi's histiocytic necrotizing lymphadenitis with cutaneous manifestations[J].J Am Acad Dermatol, 1997, 36 (2 Pt 2) :342-346.
|